Noble to address drug delivery evolution at CPhI

BioPharma Reporter

A leader from the pharma solutions firm will discuss the future of drug delivery at a keynote during the CPhI Festival of Pharma virtual event. Drug Delivery

Global Intranasal Drug Delivery Market to Reach $59.2 Billion by 2027 – ResearchAndMarkets.com

BioTech 365

DUBLIN–(BUSINESS WIRE)–The “Intranasal Drug Delivery – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Amid the COVID-19 crisis, the global market for Intranasal Drug Delivery estimated at US$44.7

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Millimetre-precision drug delivery to the brain

Scienmag

Researchers at ETH Zurich have developed a method for concentrating and releasing drugs in the brain with pinpoint accuracy. This could make it possible in the future to deliver psychiatric and cancer drugs and other medications only to those regions of the brain where this is medically desirable. Today, this is practically impossible – drugs […].

New smart drug delivery system may help treatment for neurological disorders

Scienmag

Drug delivery technology is aimed at helping people with spinal cord and other nervous system disorders Credit: KiBum Lee, Letao Yang and Brian M.

Needle-free Drug Delivery Devices Market- Roadmap for Recovery From COVID-19 | Technological Advances in Needle-free Drug Delivery Devices to Boost the Market Growth | Technavio

BioTech 365

LONDON–(BUSINESS WIRE)–#GlobalNeedlefreeDrugDeliveryDevicesMarket–Technavio has been monitoring the needle-free drug delivery devices market and it is poised to grow by USD 10.23

Novel nasal spray reduces viral replication by up to 96%: according to COVID-19 challenge study

BioPharma Reporter

Drug DeliveryEna Respiratoryâs preventative nasal spray treatment could reach human trials within four months, following results from an animal study released today which showed the spray reduced COVID-19 replication by up to 96%.

Global $73.3 Billion Nasal Drug Delivery Technology Market Trajectory & Analytics to 2027 – ResearchAndMarkets.com

BioTech 365

DUBLIN–(BUSINESS WIRE)–The “Nasal Drug Delivery Technology – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global Nasal Drug Delivery Technology Market to Reach $73.3 Billion by 2027 Amid the COVID-19 crisis, the global market for Nasal … Continue reading → Business Wire

Review Article on Floating Drug Delivery System

Pharma Tutor

The purpose of writing this review on floating drug delivery systems (FDDS) was to The recent developments of FDDS including the physiological and formulation variables affecting gastric retention, approaches to design single-unit and multiple-unit floating systems, and their classification and formulation aspects are covered in detail. It has applications also for local drug delivery to the stomach and proximal small intestines ABOUT AUTHORES .

The Current issue of “The view from here” is concerned with Cancer and Drug Delivery

Drug Discovery Today

The topics of this month’s newsletter from Drug Discovery Today are “Cancer and Drug Delivery

Ophthalmic Drug Delivery Development – Trials and Tribulations workshop

Pharma Phorum

SMi presents the 4 th Annual Ophthalmic Drugs Conference taking place on the 23 rd -24 th November 2020, in London. Workshop will be on ‘Ophthalmic Drug Delivery Development – Trials and Tribulations’. Ophthalmic Drugs Conference.

Latin America Injectable Drug Delivery Market 2019-2020 & 2028 by Device Type, Route of Administration, End-User & Region – ResearchAndMarkets.com

BioTech 365

DUBLIN–(BUSINESS WIRE)–The “Latin America Injectable Drug Delivery Market 2019-2028” report has been added to ResearchAndMarkets.com’s offering. The injectable drug delivery market in Latin America has been projected to depict growth in terms of revenue and expand with a CAGR of … Continue reading → Business Wire

Topical Drug Delivery Market by Type, Route, Patient Care Setting & COVID-19 Impact – Global Forecast to 2025 – ResearchAndMarkets.com

BioTech 365

DUBLIN–(BUSINESS WIRE)–The “Topical Drug Delivery Market by Type (Semisolids (Creams, Ointments, Gels, Lotions, Liquids, Solids, Transdermal Products), Route (Dermal, Rectal, Vaginal), Patient Care Setting (Homecare, Hospital, Burn Center) COVID-19 Impact – Global Forecast to 2025” report has been added to … Continue reading → Business Wire

Global Organ-based/Targeted Drug Delivery Devices Market for Biologics 2020 – 2030 – ResearchAndMarkets.com

BioTech 365

DUBLIN–(BUSINESS WIRE)–The “Organ-based/Targeted Drug Delivery Devices Market for Biologics (Intra-organ / Intra-tumoral), 2020 – 2030” report has been added to ResearchAndMarkets.com’s offering. Over the years, advances in cell biology and pharmacology have led to the development of a variety of … Continue reading → Business Wire

IntelGenx, ATAI partner on film-based psychedelics

Outsourcing Pharma

The companies will join forces to use IntelGenxâs polymeric film technologies for development of pharmaceutical-grade psychedelic drug treatments. Drug Delivery

Global Pharmaceutical Drug Delivery Market by Route, Application, Patient Care Setting and Region – COVID-19 Impact and Forecast 2020-2025 – ResearchAndMarkets.com

BioTech 365

DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Drug Delivery Market by Route (Oral (Tablet), Pulmonary (Nebulizer), Injectable, Ocular (Liquid), Topical (Solid), Implantable (Active), Transmucosal), Application (Cancer, Diabetes), Patient Care Setting (Hospital)- COVID-19 Impact – Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering.

A CONCISE REVIEW ON LIPOSOMES DRUG DELIVERY SYSTEM

Pharma Tutor

They are highly efficient having high drug entrapment capacity. Due to their size, hydrophobic and lipophilic character they are most widely used vehicles for drug delivery. The main aim of this drug delivery system is to target the drug directly to the site of action in order to prolong and enhance the drug effect. Liposomes are biocompatible and stable and are able to entrap both hydrophilic and lipophilic drug within its compartment.

Droplet Micron Insulin Needle Offers Innovation in Crowded Diabetes Supply Market

XTalks

This highlights the importance of optimal drug delivery, including the injection experience itself. News Medical Device News Featured Insulin Diabetes Drug Delivery Pen Needle

A mini review on nanosuspension drug delivery system : An innovative approach for poorly aqueous soluble drugs

Pharma Tutor

Scientists receive research funding from FDA to use advanced tools for assessment of drug delivery to the skin

Drug Discovery Today

Collaboration of researchers will improve imaging methods to assess extent of drug delivery to the skin – including creams and lotions for conditions like eczema

MedPharm, the leader in topical and transdermal drug delivery, has moved into its newly expanded facility in Durham, North Carolina

Drug Discovery Today

The $4M expansion has tripled the facility’s footprint to approximately 25,000 sq. ft, significantly expanding capacity and supporting MedPharm’s continued commitment to the topical and transdermal market

New drug carrier systems

Scienmag

University of Delaware researchers advance drug delivery systems to treat connective tissue disorders Credit: Graphic illustration by Jeffrey C.

Rutgers scientists develop drug-infused ‘nanoscaffolds’ to fight inflammation at the source

Journal for Clinical Studies

Scientists at Rutgers University say they’ve developed a smart drug delivery system that fights inflammation at the site of spinal… Europe Regional News

IntelGenx inks double deals to develop oral film psychedelics for psychiatric use

Journal for Clinical Studies

Drug delivery specialist IntelGenx has penned two deals to develop film-based, prescription psychedelics amid a surge of interest—and investment—from the… Europe Regional News

Entos launches US-based spinout Aegis Life, Inc. to support its global vaccine strategy

Scienmag

Entos Pharmaceuticals announces launch of US-based spinout company Aegis Life, Inc.

Advanced NanoTherapies Raises $5.3 Million in Seed-Round Financing

BioTech 365

Company accelerates development of its nanoparticle-based drug delivery technology platform to treat peripheral artery disease and other applications LOS GATOS, Calif.–(BUSINESS a privately-held medical device company committed to exploring nanotechnology for enhanced drug uptake and sustained retention, … Continue reading → Business Wire

Asahi Kasei Providing Samples of Hyaluronic Acid Nanogel as a New Pharmaceutical Excipient

BioTech 365

Inflammasome Therapeutics Receives Grant to Develop Sustained-Release Bioerodible Birth Control Implant

BioTech 365

–(BUSINESS WIRE)–Inflammasome Therapeutics, a private, science-based company developing therapies for prevalent, degenerative diseases as well as sustained-release drug delivery systems, announced it has been awarded a $1.0-million grant to develop a long-term bioerodible birth control implant. NEWTON, Mass.–(BUSINESS

Innovate UK funding for new precision cancer treatment technology

Pharma Phorum

Sixfold Bioscience in partnership with Medicines Discovery Catapult, has been given the green light, through the award of an Innovate UK Smart Grant to test a pioneering system designed to deliver drugs directly to cancerous cells, without impacting the healthy cells around it.

Free Webinar on "Prefilled Syringe Elastomer Components - High-quality Solutions for Sensitive Molecules

Drug Discovery Today

As the industry continues to see significant growth for drug products developed in prefilled syringe systems (PFS), there is a trend for pharmaceutical companies to evaluate more complex drug molecules, such as biologics.This webinar discusses current trends in the market for injectable drug delivery and outlines current challenges for companies developing drug products in a prefillable syringe system

In the News: September Regulatory and Development Updates

Camargo

ANDA applications rely on an approved product, provided in the FDA’s Orange Book as the Reference Listed Drug (RLD). Approval of the Month: FDA Approves First Closed-Loop Monitoring and Drug Delivery Device.

New speaker session with Kiniksa Pharmaceuticals at Pre-filled Syringes East Coast 2020

Pharma Phorum

Paul Roussel is currently a Senior Director of Combination Products at Kiniksa Pharmaceuticals in the CMC Technical Operations Group with over 20 years of experience in the drug delivery and medical device space.

Seattle Gummy Company Secures The First (IND) Gummy Drug Approval From FDA

The Pharma Data

Led by founder and CEO, Dr. Connie Wan , SGC redefines a household staple into a drug delivery platform to significantly increase patient’s medication compliance with its convenient and easy to take gummy medications. SEATTLE , Oct.

VirTrial Selected for COVID-19 Phase 2 Decentralized Clinical Trial

VirTrial

is an emerging biotechnology company engaged in the development and commercialization of therapeutic pharmaceuticals as well as drug delivery platform technologies. Scottsdale, AZ (October 09, 2020) – VirTrial today announced its selection by BetterLIfe Pharma Inc.

Keeping tabs on Covid-19: Starpharma creates slow release remdesivir nanoparticl…

The Pharma Data

Starpharma experimenting with Gilead’s antiviral drug for easier administration. Melbourne-based Starpharma has announced it has applied its novel DEP drug delivery technology to create a long ?

Are All Excipients Truly Inert? Maybe Not, Suggests New Study

XTalks

Excipients can take many forms, such as bulking agents, binders, coatings and colourants, and they are chosen based on their ability to aid in drug delivery, administration and even in pill identification and prevention of counterfeiting.

Bad behaviour: why understanding human behaviour can improve outcomes

Pharma Phorum

Human behaviour underpins our actions towards medication adherence, physical activity, tobacco and drug use. Prescription Digital Therapeutics (PDTs) are appearing as both a companion and a replacement to some drugs. Why did I do that?

Transitioning Between Academia and Industry: Advice from Leading Scientists That Made the Switch

XTalks

The drug is currently in clinical trials for alcoholic hepatitis (AH), nonalcoholic steatohepatitis (NASH), as well as in COVID-19 patients with acute liver or kidney injury. Before joining Nurix, Gwenn was an associate professor in the Center for Drug Discovery at Baylor College of Medicine.